...
首页> 外文期刊>Open Journal of Veterinary Medicine >Inactivated Vaccine Trial of &i&Mycoplasma gallisepticum&/i& in Ethiopia
【24h】

Inactivated Vaccine Trial of &i&Mycoplasma gallisepticum&/i& in Ethiopia

机译:i。鸡毒支原体/ i的灭活疫苗试验。在埃塞俄比亚

获取原文
           

摘要

The study and entire laboratory works were conducted from December 2014 to April 2015 in National Veterinary Institute, Bishoftu, Ethiopia. Formaldehyde inactivated Montanide ISA70 based Mycoplasma gallisepticum (MG) trial vaccine strain was confirmed the identity with known primer using PCR from locally isolates of National Veterinary Institute of Ethiopia. This study was aimed to develop formaldehyde inactivated Montanide ISA70 based MG vaccine in Ethiopia. It can help to device strategies in controlling the disease mainly through developing more effective vaccine which will replace the currently being imported vaccines by some farms. After culturing procedure, oil based inactivated MG trial vaccine was produced in suitable clean and secure accommodation. In this study, among different isolates, local isolate of Samuel farm in NVI was prepared and evaluated in chickens. The amount of immune antigen per 0.5 ml of the dose was 10~(7) Colony forming units (CFU) of the bacteria. The trail vaccine was prepared and evaluated at the age of 16 weeks of chickens; the chickens were randomly divided into three groups (A, B and C), each having twenty birds (10 male and 10 female). Each of group B was vaccinated group of imported-live vaccine with 30 μl intraocularly for comparing with inactivated trial vaccine, each bird of group C was inoculated with 0.5 ml indigenous or trial vaccine subcutaneously at mid neck region and group A was used as a control then challenge tests were performed. After challenge test, among non-vaccinated chickens (control or group A) 2 chickens were died (10%), thicken and cloudy appearance of the air sac showed 18 (90%), 2 chickens were not showed thickened and cloudy air sack (10%). Although among vaccinated group (inactivated vaccine or group C), all chickens did not show clinical signs or post mortem changes (100%). From attenuated imported live vaccine (group B), no clinical signs or post mortem changes were observed (100%). It was concluded that oil based MG vaccine induces protective level of anti MG antibodies in chickens.
机译:研究和整个实验室工作于2014年12月至2015年4月在埃塞俄比亚比索夫图的国家兽医研究所进行。使用来自埃塞俄比亚国家兽医研究所的局部分离物的PCR,用甲醛灭活的基于Montanide ISA70的鸡毒支原体(MG)试验疫苗菌株确认了与已知引物的身份。这项研究的目的是在埃塞俄比亚开发甲醛灭活的基于Montanide ISA70的MG疫苗。它可以通过开发更有效的疫苗来帮助控制疾病的策略,这些疫苗将取代某些农场目前正在进口的疫苗。培养程序后,在合适的清洁和安全环境中生产了油基灭活的MG试验疫苗。在这项研究中,在不同的分离株中,准备了NVI中Samuel农场的局部分离株并在鸡中进行了评估。每0.5 ml剂量中的免疫抗原量为细菌的10〜(7)集落形成单位(CFU)。在小鸡16周龄时制备并评估了该疫苗。将鸡随机分为三组(A,B和C),每组有二十只鸟(雄性10只,雌性10只)。 B组每只均以眼内注射30μl的进口活疫苗进行接种,以与灭活的试验疫苗进行比较,C组的每只鸡在颈部中部皮下接种0.5 ml原生或试验疫苗,A组作为对照组然后进行挑战测试。攻击试验后,未接种疫苗的鸡(对照组或A组)中有2只鸡死亡(10%),气囊的增厚和混浊外观显示18(90%),未显示增厚和气囊混浊的2只鸡( 10%)。尽管在接种疫苗的组(灭活疫苗或C组)中,所有鸡均未显示出临床体征或验尸后的变化(100%)。从减毒的进口活疫苗(B组)中,未观察到临床体征或验尸变化(100%)。结论是,油基MG疫苗可诱导鸡抗MG抗体的保护水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号